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THE protection that can be demonstrated following the incubation of certain
tumour cells with iso-immune sera in vitro is in striking contrast with the failure
of the same sera to protect passively in vivo (see review by Hauschka, 1952),
but before these findings can be interpreted it should be shown that the conditions
obtaining in the body are as favourable for protection as those produced in vitro.
There are a number of factors that might be responsible for the failure of
serum to protect, few of which have received sufficient attention. Foremost is
the question of the activity of the serum, and of the relationship between this
activity and the cell dose. Activity may either be measured in terms ofprotection
or through some non-functional property, such as agglutinating power. The
former would be too costly both in time and in animals for regular use, the measure-
ment of the second has only recently been made simple and reliable following the
introduction of the DIextran technique (Gorer and Mikulska, 1954). Consequently
most of the work has been done on unstandardised serum. Similarly the cell
dose has received little attention, although it is well known that a given volume
of serum will only protect against a limited number of cells. Many experiments
have been performed using a lumpy suspension or even solid fragments of tumour,
in which case it is probable that serum cannot penetrate to the centre of the mass
before the transplant is established. Under these circumstances it is not sur-
prising that success has not been reported.
The object of this investigation was to provide a possible basis for a future
attack on problems of passive immunity to tumours. During the course of the
work it became apparent that the method would be useful for detecting antigens
in genetical experiments and the second part of the paper is devoted to the results
obtained.
MATERIALS AND METHODS.
The origin of the four pure line strains of mice, A, Bagg albino C (Balb.C),
C3H and C57 Black, together with a description of the C57 Black leukosis E.L.4,
the production of antibodies, and details of the Dextran method of haemagglutin-
ation have already been published (Gorer and Mikulska, 1954).
After a few preliminary experiments in which the intravenous route was
used, all antibodies were injected into the peritoneum. 01 ml. of serum was
introduced into the peritoneal cavity through a fine-bore needle, care being
taken to avoid leaking back. Equilibrium was reached in the bloodstream within
an hour in homologous animals. When blood was required for testing, the
animals were warmed to 37° C. before being anaesthetised with ether and bled from
the tail. It was found that enough blood for titration could always be obtainedPERSISTENCE OF MOUSE ISO-ANTIBODIES
from a single mouse. The serum was removed from the clot and titrated immedi-
ately or stored in ampoules at- 20° C. for not more than 3 days. In some
experiments designed to test for the persistence of antibodies, and in the genetical
experiments, a single individual was bled; in the others, groups of three were
bled simultaneously and the serum either pooled or titrated individually.
Backcross mice. A backcross called the C backcross was obtained by mating
Balb.C with C57 Black, and crossing the resultant F1 with Balb.C.
Protection. The simple technique already described (Gorer, 1942) has been
followed. Fresh leukotic cells from ascitic fluid were suspended in normal
mouse serum at a concentration of about one million cells in 0.1 ml. From this
stock suspension a series of dilutions in normal serum was made covering the
range required. An equal volume of immune serum was added and the mixture
allowed to stand on the bench for 15-20 minutes and then inoculated subcutane-
ously into susceptible mice.
RESULTS.
Persistence of antibodies against E.L.4.
The antibodies studied here are those developed against the hist-compatibility
system known as H-2 (Gorer, Lyman and Snell, 1948), which appears to be
similar to the Rh system in man. Individual components are often shared
between different strains, so that antibodies against E.L.4. produced in one
strain will usually also agglutinate cells of other strains (Amos, 1953; Gorer and
Mikulska, 1954 Hoecker, Counce and Smith, 1954); and antibodies may be
detected by the use of several different red cells. In general, A strain cells are
the most readily agglutinated and provide the most sensitive indicator of the
presence of antibody.
After antibodies have been passaged through the homologous strain their
agglutination reactions are similar to those of the original serum, but of lower
titre owing to some degree of dilution. Thus Balb.C. anti E.L.4 may have an
initial titre of 1/4000 for A cells and 1/2000 for C57B1 cells. After passage for
24 hours in Balb.C these values would be in the region of 1/256 for A cells and
1/128 for C57B1., the titres falling slowly during the next 10 days to 1/16-1/32
and 1/4-1/16 respectively. Two such die-away curves are shown in Fig. 1.
Here Balb.C anti E.L.4 has been injected into Ba]b.C, and C3H anti E.L.4 into
C3H mice, the animals have been bled at intervals and the titres of circulating
antibodies estimated against C57B1. cells. For Balb.C anti E.L.4 the titre
after 24 hours was 1/256 this level slowly falling to 1/16 after 8 days, the C3H
anti E.L.4 was a less active serum and from an initial level of 1/64 fell to 1/8
after the same interval.
The titre of circulating antibody after 18 hours is proportional to the amount
of serum injected, for a range studied from 0-01 ml. to 0.2 ml. For 0.1 ml. of
serum the dilution appears to be about 1/20. Assuming the blood volume to be
63.2 c.c. per kilo (Oakley and Warrack, 1940) and the haematocrit 43 per cent
(Wintrobe, 1933) for mice of about 25 g. in weight, the serum volume would be
approximately 0-7 ml. and would account for a dilution of about 1/8, so that
rather more than half of the serum is being lost from the circulation, probably
into the lymphatic and extracellular fluids.
In six separate experiments lasting from 8 to 12 days haemagglutinins prepared
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against E.L.4 have been found to persist for a considerable timne, and although
there was too much variation between different samples of antibody for an
accurate assessment of half-life, this was of the order of the value given by other
workers (Dixon et al., 1952). In some of the experiments there tended to be an
initial period of up to 8 days in which the titre remained constant and then fell
at about the usual rate. This lag was most noticeable when large amounts or
exceptionally high titre sera were used, and was most marked with A strain red
cells. Haemagglutination does not provide a good indicator for estimating
half-life, but is a valuable method for detecting the continuing presence of
antibody.
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FiGo. 1.-The persistence of antibodies against E.L.4 in the homologous strain;
titrated against C57B1. cells.
Protective antibodies also survive passage through the homologous strain,
0-2 of Balb.C anti E.L.4 was inoculated into some Balb.C mice which were bled
out after 2 days. A protection experiment was then set up using 20,000 leukotic
cells with 0.1 ml. of passaged antibody in the experimental group and 10,000 and
20,000 cells in normal serum for the controls. The control mice all developed
tumours by the 13th day whilst 0.1 ml. of passaged antibody gave complete
protection for 34 days, when the experiment was discontinued. A similar
experiment in which a different serum was passaged for 3 days gave the same
result.
The circulating antibody can also be absorbed by free leukaemic cells, but
apparently not by cells outside the circulation. Three groups of Balb.C mice
were taken, the control was given 0.1 ml. Balb.C anti E.L.4 alone, the first experi-
mental group was given the same dose of antibody intraperitoneally followed
almost immediately by 0-2 ml. of packed E.L.4 cells intravenously, the second
was given the same dose of E.L.4 intravenously but the serum was only given
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after 18 hours. Serum from the first group gave a titre of only 1/4 against C57B1.
cells, whilst for the controls and the second experimental group the titres were
1/32-1/64. Another experiment along similar lines was performed when homolog-
ous antibody was given to a group of six Balb.C mice that had actively growing
tumours ofE.L.4. The course ofthe transplanted leukosis in Balb.C is ofprogres-
sive growth up to 7-8 days followed by rapid regression at about the 10th day,
antibodies are not detectable in the blood until the tumour begins to regress.
In this case the antibody titre in the animals with growing tumours followed
closely the titre in a control group without tumours until the 9th day, when there
was an abrupt rise in titre in the experimental group, so that whilst E.L.4 will
absorb antibodies when freely circulating in the blood stream, it is unable to do
so when established in the tissues. This failure to absorb by the growing tumours
cannot be ascribed to saturation with locally produced antibody, as similar
tumours absorb quite readily in vitro, but must be due to lack ofintimate contact
between the antibody and leukaemic cells. It can readily be seen that the use of
tumour fragments could lead to the same result, probably purely a mechanical
effect.
In vivo absorption. In contradistinction to their prolonged survival in the
homologous strain, passively transferred antibodies are quickly removed in the
presence of the corresponding antigen. When 0.1 ml. of Balb.C anti E.L.4 was
given intravenously to C57B1. the titre against A cells after 5 minutes had fallen
to 1/16, after 15 minutes to 1/4 and after 30 minutes could no longer be detected,
the titre in Balb.C given the same dose remaining at 1/256. Even when the
relatively enormous dose of 0.5 ml. of the same serum was given intravenously
to the blacks the level after one hour was only 1/4, and after two hours the agglutin-
ating antibodies had been completely absorbed.
This degree of absorption could not have been achieved by the red cells alone.
Details of the antigenic structure of E.L.4 will be given by Gorer and Mikulska
in a later paper, so that here it is sufficient to mention two ofthe antigens involved.
The antigenic component H2-B is present in E.L.4 and in the tissues and red
cells of C57B1., H2-E is present in E.L.4 and the fixed tissues of C57B1. is doubt-
fully present on the red cells; it is however shared by other strains and is present
on the red cells of the A strain. After repeated absorption with C57B1. red
cells Balb.C anti E.L.4 will still agglutinate A strain red cells, C57B1. liver and
E.L.4 will remove all the agglutinins. The removal of the antibodies by the
blacks in vivo must therefore be due to contact with other cells, probably those of
the bone-marrow and possibly by the cells of the liver and splenic sinusoids, etc.
TABLE I.-Comparison between Absorption with Liver and in vivo Absorption
ofAntibodies against E.L.4.
Titre* after
absorption with Titre* after
liver from: passage through:
Titre* r ,
Antibody. Tested on. unabsorbed. A. Balb.C. A. Balb.C.
Balb.C anti-E.L.4 JA cells . Over 2000 . 0 1024 . 0 256 *C57BI. cells Over 2000 . 256 1024 32-64 64
CHati-FfL4A cells . 256-2048 . 0 0 . 0 0 3H ant-.L. * C57BI. cells . 512-4000 . 256-512 256-512 . 64 32-64
* Titres expressed as reciprocals.
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A comparison of some results obtained by in vivo and in vitro absorption
is given in Table I. For the antibody Balb.C anti E.L.4, A strain liver removes
all the antibodies against its own cells and lowers the titre against C57B1. cells
from over 1/2,000 to 1/256, a control absorption with Balb.C liver lowers the
titre against both cells slightly. Figures for the in vivo absorption are similar,
but the titres are lower. A similar situation occurs with C3H anti E.L.4 where
both A and Balb.C remove the agglutinins against A cells but not against C57B1.
Although there has been a considerable degree of dilution in the in vivo series
the results are clear cut and there does not appear to have been any untoward
degree of non-specific absorption. There is little point in using the technique
to study the absorptive capacities ofpure line strains, as liver is readily available;
but in a genetical experiment the individual mouse may be valuable either for
use in further experiments or for breeding. Any number of in vivo absorptions
can be carried out provided they are adequately spaced.
TABLE II.-Serological Typing of C backcross mice by direct Agglutination and
by in vivo Absorption.
In vivo absorbed serum
Direct agglutination tested on:
Balb.C A A cells C57B1. cells
MAlouse No. anti-E.L.4. anti-E.L.4. Balb.C anti-E.L.4. A anti-E.L.4.
17 - --+
20 . + + . - -
21 . + + . -
23 . - - . + +
29 . + + . - -
36 . - - . + +
In any serological typing of a genetical experiment there are always a few
animals giving weak reactions. Somne of these may be due to the serum used
containing antibodies against subsidiary antigens (Amos, Gorer, Mikulska, 1955),
simply repeating the direct agglutination with a different serum may serve to
distinguish these. The classification of the others can only be decided by absorp-
tion. Red cell absorption is impracticable for removing " Dextran" antibodies,
so that in vivo absorption is the method of choice. Table II shows some results
of such an absorption with C backcross mice. The columnns on the left show the
results of direct agglutination with Balb.C anti E.L.4 and A anti E.L.4, the former
detecting the presence of the antigens H2-B and H2-E, the latter H2-B. On
the right is shown the result of testing the same two sera after passage through
the backcross mice. Where the antigen is shown to be present on direct agglutin-
ation the corresponding antigen is removed by in vivo absorption. Mouse 17
gave a positive result with Balb.C anti-E.L.4 but not A anti-E.L.4 on direct
testing, and this result was again obtained when the mouse was tested with a
different serum. In vivo absorption showed that the H-2 antibodies were not
absorbed, the reaction was due to some subsidiary antibody.
Although the technique is very straightforward, there are a few precautions
that must be taken. Different sera must not be given at intervals of less than
3-4 weeks in order to allow the residual antibodies to decay and to allow the
animal to make good the blood loss. Because animals used in a genetical experi-
ment may have less of the antigen than the pure line it is advisable to allow 18
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hours to elapse before bleeding. Finally, it is important to avoid sera from mice
that have been too strongly immunised, as these may contain subsidiary anti-
bodies which may give rise to difficulty in the interpretation of results.
DISCUSSION.
Gorer (1942) suggested that haemagglutinins and protective antibodies were
distinct entities but this conclusion was based upon results with saline agglutin-
ation, which is an inefficient method of detecting antibodies and at that time
the extreme complexity ofthe H-2 system was unknown. However, the statement
maywell be correct. Even ifthat is so, itis possible that the stabilityofprotective
antibody may be similar to that of the haemagglutinins. Experiments with Dr.
Gorer indicate that their stability in vitro is similar and the protection experiments
reported above indicate that this is also true in vivo. It would seem therefore that
the decay of antibody is not too rapid to render passive immunisation impossible,
but it would be unreasonable to expect success with cell dosages that are far
beyond the power of a serum to inhibit when mixed in vitro prior to inoculation.
SUMMARY AND CONCLUSIONS.
When antibodies against a C57 Black leukosis E.L.4 are inoculated into non-
immune homologous mice they may be detected in the bloodstream for as long
as 12 days. Variations are too great for an estimate of the half-life to be made,
but this appeared to be at least two days and in some cases longer.
Protective antibodies can also be detected in the blood of similarly treated
animals for at least 3 days.
Passage through backcross mice results in absorption ofantibodies by animals
having the corresponding antigen.
My thanks are due to Dr. P. A. Gorer for helpful criticism and advice and to
Mrs. Z. B. Mikulska for titrating some of the sera.
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